HRP20190193T1 - Novi derivati fosfanina i azofosfanina,postupak njihove priprave te farmaceutski pripravci koji ih sadrže - Google Patents

Novi derivati fosfanina i azofosfanina,postupak njihove priprave te farmaceutski pripravci koji ih sadrže

Info

Publication number
HRP20190193T1
HRP20190193T1 HRP20190193TT HRP20190193T HRP20190193T1 HR P20190193 T1 HRP20190193 T1 HR P20190193T1 HR P20190193T T HRP20190193T T HR P20190193TT HR P20190193 T HRP20190193 T HR P20190193T HR P20190193 T1 HRP20190193 T1 HR P20190193T1
Authority
HR
Croatia
Prior art keywords
same
azaphosphinane
phosphinane
derivatives
novel
Prior art date
Application number
HRP20190193TT
Other languages
English (en)
Inventor
Philippe Gloanec
Arnaud-Pierre Schaffner
Patricia Sansilvestri-Morel
Alain Rupin
Philippe Mennecier
Marie-Odile Vallez
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55752640&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20190193(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20190193T1 publication Critical patent/HRP20190193T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6568Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65846Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
HRP20190193TT 2016-01-14 2019-01-30 Novi derivati fosfanina i azofosfanina,postupak njihove priprave te farmaceutski pripravci koji ih sadrže HRP20190193T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1670004A FR3046793B1 (fr) 2016-01-14 2016-01-14 Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP17706525.7A EP3271368B1 (fr) 2016-01-14 2017-01-13 Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2017/050075 WO2017121969A1 (fr) 2016-01-14 2017-01-13 Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HRP20190193T1 true HRP20190193T1 (hr) 2019-04-05

Family

ID=55752640

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20190193TT HRP20190193T1 (hr) 2016-01-14 2019-01-30 Novi derivati fosfanina i azofosfanina,postupak njihove priprave te farmaceutski pripravci koji ih sadrže

Country Status (47)

Country Link
US (2) US10138260B2 (hr)
EP (1) EP3271368B1 (hr)
JP (1) JP2019504070A (hr)
KR (1) KR20180101522A (hr)
CN (1) CN108495857A (hr)
AR (1) AR107433A1 (hr)
AU (1) AU2017207003B2 (hr)
BR (1) BR112018014020A2 (hr)
CA (1) CA3011184C (hr)
CL (1) CL2018001862A1 (hr)
CO (1) CO2018007271A2 (hr)
CU (1) CU20180072A7 (hr)
CY (1) CY1121154T1 (hr)
DK (1) DK3271368T3 (hr)
DO (1) DOP2018000165A (hr)
EA (1) EA035072B1 (hr)
EC (1) ECSP18051972A (hr)
ES (1) ES2709376T3 (hr)
FR (1) FR3046793B1 (hr)
GE (1) GEP20207092B (hr)
HK (1) HK1244283B (hr)
HR (1) HRP20190193T1 (hr)
HU (1) HUE042924T2 (hr)
IL (1) IL260425B (hr)
JO (1) JO3660B1 (hr)
LT (1) LT3271368T (hr)
MA (1) MA41798B1 (hr)
MD (1) MD3271368T2 (hr)
ME (1) ME03305B (hr)
MX (1) MX367319B (hr)
NI (1) NI201800073A (hr)
PE (1) PE20181503A1 (hr)
PH (1) PH12018501373B1 (hr)
PL (1) PL3271368T3 (hr)
PT (1) PT3271368T (hr)
RS (1) RS58338B1 (hr)
RU (1) RU2729641C2 (hr)
SG (1) SG11201805757WA (hr)
SI (1) SI3271368T1 (hr)
SV (1) SV2018005721A (hr)
TN (1) TN2018000226A1 (hr)
TR (1) TR201820430T4 (hr)
TW (1) TWI625334B (hr)
UA (1) UA121275C2 (hr)
UY (1) UY37072A (hr)
WO (1) WO2017121969A1 (hr)
ZA (1) ZA201804391B (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3046793B1 (fr) * 2016-01-14 2018-01-05 Les Laboratoires Servier Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK1732003A3 (en) * 2000-08-17 2004-08-03 Pfizer Substituted imidazoles as TAFIa inhibitors
SE0103272D0 (sv) * 2001-09-28 2001-09-28 Astrazeneca Ab Chemical compounds
WO2003076416A1 (en) * 2002-03-08 2003-09-18 Warner-Lambert Company Llc Oxo azabicyclic compounds
US7420000B2 (en) * 2003-09-10 2008-09-02 University Of Southern California Amino phosphonate and amino bis-phosphonate derivatives
US20050143349A1 (en) * 2003-12-17 2005-06-30 Quatrx Pharmaceuticals Co. Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels
JP2008536923A (ja) * 2005-04-18 2008-09-11 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 心筋の再灌流の増強およびpciの容易化のためのtafi阻害剤の使用
AU2008266883B2 (en) * 2007-06-20 2014-01-30 Merck Sharp & Dohme Corp. Inhibitors of janus kinases
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2947266B1 (fr) * 2009-06-26 2011-06-17 Servier Lab Nouveaux derives d'acide 2-mercaptocyclopentanecarboxylique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT2507249E (pt) * 2009-09-09 2016-02-15 Gilead Sciences Inc Inibidores de vírus flaviviridae
JP6186434B2 (ja) * 2012-07-18 2017-08-23 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. 窒素複素環誘導体及びその医薬品への応用
FR3046793B1 (fr) * 2016-01-14 2018-01-05 Les Laboratoires Servier Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
RS58338B1 (sr) 2019-03-29
CL2018001862A1 (es) 2018-10-05
ES2709376T3 (es) 2019-04-16
TN2018000226A1 (fr) 2019-10-04
ECSP18051972A (es) 2018-07-31
UA121275C2 (uk) 2020-04-27
CA3011184A1 (fr) 2017-07-20
MX2018008639A (es) 2018-11-19
RU2018129027A (ru) 2020-02-14
MD3271368T2 (ro) 2019-03-31
JP2019504070A (ja) 2019-02-14
ZA201804391B (en) 2020-01-29
DK3271368T3 (da) 2019-02-25
RU2729641C2 (ru) 2020-08-11
US10138260B2 (en) 2018-11-27
HUE042924T2 (hu) 2019-07-29
SG11201805757WA (en) 2018-08-30
PL3271368T3 (pl) 2019-04-30
PH12018501373A1 (en) 2019-02-27
LT3271368T (lt) 2018-12-10
AU2017207003B2 (en) 2020-10-08
US20190031693A1 (en) 2019-01-31
PE20181503A1 (es) 2018-09-18
SI3271368T1 (sl) 2019-02-28
CO2018007271A2 (es) 2018-07-19
EP3271368A1 (fr) 2018-01-24
FR3046793A1 (fr) 2017-07-21
TW201726697A (zh) 2017-08-01
SV2018005721A (es) 2018-09-06
AU2017207003A2 (en) 2018-10-04
KR20180101522A (ko) 2018-09-12
TWI625334B (zh) 2018-06-01
NI201800073A (es) 2018-09-06
PH12018501373B1 (en) 2019-02-27
BR112018014020A2 (pt) 2018-12-11
EA201891599A1 (ru) 2019-01-31
FR3046793B1 (fr) 2018-01-05
WO2017121969A1 (fr) 2017-07-20
DOP2018000165A (es) 2018-09-15
CN108495857A (zh) 2018-09-04
CY1121154T1 (el) 2020-05-29
MA41798B1 (fr) 2018-11-30
JO3660B1 (ar) 2020-08-27
EP3271368B1 (fr) 2018-10-31
US20180016288A1 (en) 2018-01-18
CU20180072A7 (es) 2018-10-04
HK1244283B (zh) 2019-11-22
US10654878B2 (en) 2020-05-19
ME03305B (me) 2019-10-20
AR107433A1 (es) 2018-05-02
MA41798A (fr) 2018-01-24
TR201820430T4 (tr) 2019-01-21
RU2018129027A3 (hr) 2020-03-19
CA3011184C (fr) 2020-09-29
PT3271368T (pt) 2018-12-04
EA035072B1 (ru) 2020-04-23
UY37072A (es) 2017-07-31
MX367319B (es) 2019-08-15
AU2017207003A1 (en) 2018-07-26
GEP20207092B (en) 2020-04-10
IL260425B (en) 2020-05-31

Similar Documents

Publication Publication Date Title
HK1254656A1 (zh) 新的二環衍生物、其製備方法以及含有它們的藥物組合物
ZA201708663B (en) Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
HRP20181806T1 (hr) Novi aminokiselinski derivati, postupak za njihovu pripravu te farmaceutski pripravci koji ih sadrže
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
EP3351242A4 (en) ORAL PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID, PROCESS FOR PREPARATION AND USE THEREOF
HK1231416A1 (zh) 西羅莫司及其衍生物的絡合物、其製備方法以及含有其的藥物組合物
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
IL274141A (en) New macrocyclic compounds, a process for their preparation and pharmaceutical preparations containing them
HRP20190193T1 (hr) Novi derivati fosfanina i azofosfanina,postupak njihove priprave te farmaceutski pripravci koji ih sadrže